Lastly, in the experiment of ex vivo IL-15 treatment with human RCC samples, we compared proliferation between pre- and post-treatment without including a media control group because we conducted other phenotypic analyses simultaneously with the limited number of cells obtained. The gene discussed is IL15; the disease is renal cell carcinoma.